Best for
Mobile

Posted
Veeva Systems Inc is a health information services business based in the US. Veeva Systems shares (VEEV.US) are listed on the NYSE and all prices are listed in US Dollars. Veeva Systems employs 3,501 staff and has a trailing 12-month revenue of around $1.4 billion.
Best for
Mobile
Best for
Low-cost
Best for
All rounder
Best for
Beginners
Latest market close | $N/A |
---|---|
52-week range | $118.11 - $313.99 |
50-day moving average | $275.9873 |
200-day moving average | $273.3163 |
Wall St. target price | $312 |
PE ratio | 134.7759 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $2.142 |
Other fees may apply. Your capital is at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Veeva Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Veeva Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Veeva Systems's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 135x. In other words, Veeva Systems shares trade at around 135x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Veeva Systems's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.1113. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Veeva Systems's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Veeva Systems's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $371.6 million.
The EBITDA is a measure of a Veeva Systems's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $1.4 billion |
---|---|
Operating margin TTM | 24.69% |
Gross profit TTM | $800.7 million |
Return on assets TTM | 9.5% |
Return on equity TTM | 18.73% |
Profit margin | 24.88% |
Book value | $13.923 |
Market capitalisation | $43.7 billion |
TTM: trailing 12 months
There are currently 1.9 million Veeva Systems shares held short by investors – that's known as Veeva Systems's "short interest". This figure is 12.7% down from 2.1 million last month.
There are a few different ways that this level of interest in shorting Veeva Systems shares can be evaluated.
Veeva Systems's "short interest ratio" (SIR) is the quantity of Veeva Systems shares currently shorted divided by the average quantity of Veeva Systems shares traded daily (recently around 1.1 million). Veeva Systems's SIR currently stands at 1.67. In other words for every 100,000 Veeva Systems shares traded daily on the market, roughly 1670 shares are currently held short.
However Veeva Systems's short interest can also be evaluated against the total number of Veeva Systems shares, or, against the total number of tradable Veeva Systems shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Veeva Systems's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Veeva Systems shares in existence, roughly 10 shares are currently held short) or 0.0137% of the tradable shares (for every 100,000 tradable Veeva Systems shares, roughly 14 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Veeva Systems.
Find out more about how you can short Veeva Systems stock.
We're not expecting Veeva Systems to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Veeva Systems's shares have ranged in value from as little as $118.11 up to $313.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Veeva Systems's is 0.8309. This would suggest that Veeva Systems's shares are less volatile than average (for this exchange).
Subscribe to trending stock alerts for a chance to win
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, commercial data warehouse, allocation and alignment applications, master data management application, and data and services; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. Veeva Systems has collaboration with RedHill Biopharma Ltd. to enhance value of Opaganib Phase 2/3 COVID-19 clinical data. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was founded in 2007 and is headquartered in Pleasanton, California.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.